Portfolio: Investments

Somaxon Pharmaceuticals, Inc.
Specialty pharmaceuticals for neurology and psychiatry

Surface Logix
Drugs for obesity, diabetes and cardiovascular diseases

Syndax Pharmaceuticals, Inc.
Novel combination regimens for cancer

Taigen Biotechnology Company, Ltd.
GPC receptor agonists and antagonists

Tercica, Inc.
Acquired by Ipsen

Theraclone Sciences
Novel tumor-specific therapeutic antibodies